K.	Kaempheria
Sp.	Species
PCA	Principal component analysis
AHC	Agglomerative hierarchical clustering
CCA	Significant Cholangiocarcinoma
HSC-2	Mouth squamous cell carcinoma
EAC	Ehrlich ascites carcinoma cancer cells
HL-60	Human leukemia cancer cells
CL-6	Human cholangiocarcinoma cells
TKI	Tyrosine kinase inhibitors
BCRP	Breast cancer resistance protein
MTT	(3-[4,5,[4,5-Dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) assay
CH2Cl2	Dichloromethane
BChE	Butyrylcholinesterase
NO	Nitric oxide
CUPRAC	Modified cupric reducing antioxidant capacity
PDE5	Phosphodiesterase type 5 inhibitor
AP	Aerial parts
AChE	Acetylcholinesterase
RBL-2H3	Rat Basophilic Leukemia cells
P38	Type of mitogen-activated protein kinases
STAT1 and 3	Signal transducers and activators of transcription 1 and 3
MeOH	Methanol
EtOAc	Ethyl acetate
MCF-7	Breast cancer cells
HT-29	Colorectal adenocarcinoma cell
PMF	Polymethoxyflavonoid-rich fraction
TSOD	Tsumura Suzuki obese diabetes
GGPP	(E,E,E)-Geranylgeranyl diphosphate
CPP	Copalyl diphosphate
CPS	Copalyl diphosphate synthases
EtOH	Ethanol
AChE	Acetylcholinesterase
ABTS	2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) assay
Vpr	Viral protein R
DPPH	1,1-Diphenyl-2-picrylhydrazyl assay
FRAP	Ferric reducing antioxidant power
CYP3A	Cytochrome P450, family 3, subfamily A
NF-κB	Nuclear factor pathway
Rh	Rhizomes
BChE	Butyrylcholinesterase
STZ	Streptozotocin
MPO	myeloperoxidase
DMF	Dimethylformamide
MAPKs	Type of mitogen-activated protein kinases
PGE2	Prostaglandin E2